The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antiinfective API Market Research Report 2025
Synopsis
Anti-infective drugs refer to various drugs used to treat infections caused by pathogens. The API is the raw material made from these drugs.
The global Antiinfective API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiinfective API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiinfective API.
Report Scope
The Antiinfective API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiinfective API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiinfective API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ACS Dobfar
Sterile India
Nectar Lifesciences
Kopran
Qilu Pharmaceutial
Hangzhou Viwa
Daewoong Bio
Fresenius Kabi iPSUM
Sinopharm Weiqida Pharmaceutical
Virchow Healthcare
United Laboratories International Holdings
Dawnrays
CSPC Pharmaceutical
Orchid Pharma
Guangzhou Pi & Pi Biotech
Segment by Type
Respiratory Infections API
Skin Infections API
Other
Segment by Application
Oral Medicine
Injection
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antiinfective API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Antiinfective API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Antiinfective API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Anti-infective drugs refer to various drugs used to treat infections caused by pathogens. The API is the raw material made from these drugs.
The global Antiinfective API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiinfective API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiinfective API.
Report Scope
The Antiinfective API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiinfective API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiinfective API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ACS Dobfar
Sterile India
Nectar Lifesciences
Kopran
Qilu Pharmaceutial
Hangzhou Viwa
Daewoong Bio
Fresenius Kabi iPSUM
Sinopharm Weiqida Pharmaceutical
Virchow Healthcare
United Laboratories International Holdings
Dawnrays
CSPC Pharmaceutical
Orchid Pharma
Guangzhou Pi & Pi Biotech
Segment by Type
Respiratory Infections API
Skin Infections API
Other
Segment by Application
Oral Medicine
Injection
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antiinfective API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Antiinfective API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Antiinfective API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Antiinfective API Market Overview
1.1 Product Definition
1.2 Antiinfective API Segment by Type
1.2.1 Global Antiinfective API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Respiratory Infections API
1.2.3 Skin Infections API
1.2.4 Other
1.3 Antiinfective API Segment by Application
1.3.1 Global Antiinfective API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Oral Medicine
1.3.3 Injection
1.4 Global Market Growth Prospects
1.4.1 Global Antiinfective API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Antiinfective API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Antiinfective API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Antiinfective API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Antiinfective API Production Market Share by Manufacturers (2019-2024)
2.2 Global Antiinfective API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Antiinfective API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Antiinfective API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Antiinfective API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Antiinfective API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Antiinfective API, Product Offered and Application
2.8 Global Key Manufacturers of Antiinfective API, Date of Enter into This Industry
2.9 Antiinfective API Market Competitive Situation and Trends
2.9.1 Antiinfective API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Antiinfective API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Antiinfective API Production by Region
3.1 Global Antiinfective API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Antiinfective API Production Value by Region (2019-2030)
3.2.1 Global Antiinfective API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Antiinfective API by Region (2025-2030)
3.3 Global Antiinfective API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Antiinfective API Production by Region (2019-2030)
3.4.1 Global Antiinfective API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Antiinfective API by Region (2025-2030)
3.5 Global Antiinfective API Market Price Analysis by Region (2019-2024)
3.6 Global Antiinfective API Production and Value, Year-over-Year Growth
3.6.1 North America Antiinfective API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Antiinfective API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Antiinfective API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Antiinfective API Production Value Estimates and Forecasts (2019-2030)
4 Antiinfective API Consumption by Region
4.1 Global Antiinfective API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Antiinfective API Consumption by Region (2019-2030)
4.2.1 Global Antiinfective API Consumption by Region (2019-2024)
4.2.2 Global Antiinfective API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Antiinfective API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Antiinfective API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Antiinfective API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Antiinfective API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Antiinfective API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Antiinfective API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Antiinfective API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Antiinfective API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Antiinfective API Production by Type (2019-2030)
5.1.1 Global Antiinfective API Production by Type (2019-2024)
5.1.2 Global Antiinfective API Production by Type (2025-2030)
5.1.3 Global Antiinfective API Production Market Share by Type (2019-2030)
5.2 Global Antiinfective API Production Value by Type (2019-2030)
5.2.1 Global Antiinfective API Production Value by Type (2019-2024)
5.2.2 Global Antiinfective API Production Value by Type (2025-2030)
5.2.3 Global Antiinfective API Production Value Market Share by Type (2019-2030)
5.3 Global Antiinfective API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Antiinfective API Production by Application (2019-2030)
6.1.1 Global Antiinfective API Production by Application (2019-2024)
6.1.2 Global Antiinfective API Production by Application (2025-2030)
6.1.3 Global Antiinfective API Production Market Share by Application (2019-2030)
6.2 Global Antiinfective API Production Value by Application (2019-2030)
6.2.1 Global Antiinfective API Production Value by Application (2019-2024)
6.2.2 Global Antiinfective API Production Value by Application (2025-2030)
6.2.3 Global Antiinfective API Production Value Market Share by Application (2019-2030)
6.3 Global Antiinfective API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 ACS Dobfar
7.1.1 ACS Dobfar Antiinfective API Corporation Information
7.1.2 ACS Dobfar Antiinfective API Product Portfolio
7.1.3 ACS Dobfar Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 ACS Dobfar Main Business and Markets Served
7.1.5 ACS Dobfar Recent Developments/Updates
7.2 Sterile India
7.2.1 Sterile India Antiinfective API Corporation Information
7.2.2 Sterile India Antiinfective API Product Portfolio
7.2.3 Sterile India Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Sterile India Main Business and Markets Served
7.2.5 Sterile India Recent Developments/Updates
7.3 Nectar Lifesciences
7.3.1 Nectar Lifesciences Antiinfective API Corporation Information
7.3.2 Nectar Lifesciences Antiinfective API Product Portfolio
7.3.3 Nectar Lifesciences Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Nectar Lifesciences Main Business and Markets Served
7.3.5 Nectar Lifesciences Recent Developments/Updates
7.4 Kopran
7.4.1 Kopran Antiinfective API Corporation Information
7.4.2 Kopran Antiinfective API Product Portfolio
7.4.3 Kopran Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Kopran Main Business and Markets Served
7.4.5 Kopran Recent Developments/Updates
7.5 Qilu Pharmaceutial
7.5.1 Qilu Pharmaceutial Antiinfective API Corporation Information
7.5.2 Qilu Pharmaceutial Antiinfective API Product Portfolio
7.5.3 Qilu Pharmaceutial Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Qilu Pharmaceutial Main Business and Markets Served
7.5.5 Qilu Pharmaceutial Recent Developments/Updates
7.6 Hangzhou Viwa
7.6.1 Hangzhou Viwa Antiinfective API Corporation Information
7.6.2 Hangzhou Viwa Antiinfective API Product Portfolio
7.6.3 Hangzhou Viwa Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Hangzhou Viwa Main Business and Markets Served
7.6.5 Hangzhou Viwa Recent Developments/Updates
7.7 Daewoong Bio
7.7.1 Daewoong Bio Antiinfective API Corporation Information
7.7.2 Daewoong Bio Antiinfective API Product Portfolio
7.7.3 Daewoong Bio Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Daewoong Bio Main Business and Markets Served
7.7.5 Daewoong Bio Recent Developments/Updates
7.8 Fresenius Kabi iPSUM
7.8.1 Fresenius Kabi iPSUM Antiinfective API Corporation Information
7.8.2 Fresenius Kabi iPSUM Antiinfective API Product Portfolio
7.8.3 Fresenius Kabi iPSUM Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Fresenius Kabi iPSUM Main Business and Markets Served
7.7.5 Fresenius Kabi iPSUM Recent Developments/Updates
7.9 Sinopharm Weiqida Pharmaceutical
7.9.1 Sinopharm Weiqida Pharmaceutical Antiinfective API Corporation Information
7.9.2 Sinopharm Weiqida Pharmaceutical Antiinfective API Product Portfolio
7.9.3 Sinopharm Weiqida Pharmaceutical Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Sinopharm Weiqida Pharmaceutical Main Business and Markets Served
7.9.5 Sinopharm Weiqida Pharmaceutical Recent Developments/Updates
7.10 Virchow Healthcare
7.10.1 Virchow Healthcare Antiinfective API Corporation Information
7.10.2 Virchow Healthcare Antiinfective API Product Portfolio
7.10.3 Virchow Healthcare Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Virchow Healthcare Main Business and Markets Served
7.10.5 Virchow Healthcare Recent Developments/Updates
7.11 United Laboratories International Holdings
7.11.1 United Laboratories International Holdings Antiinfective API Corporation Information
7.11.2 United Laboratories International Holdings Antiinfective API Product Portfolio
7.11.3 United Laboratories International Holdings Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 United Laboratories International Holdings Main Business and Markets Served
7.11.5 United Laboratories International Holdings Recent Developments/Updates
7.12 Dawnrays
7.12.1 Dawnrays Antiinfective API Corporation Information
7.12.2 Dawnrays Antiinfective API Product Portfolio
7.12.3 Dawnrays Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Dawnrays Main Business and Markets Served
7.12.5 Dawnrays Recent Developments/Updates
7.13 CSPC Pharmaceutical
7.13.1 CSPC Pharmaceutical Antiinfective API Corporation Information
7.13.2 CSPC Pharmaceutical Antiinfective API Product Portfolio
7.13.3 CSPC Pharmaceutical Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 CSPC Pharmaceutical Main Business and Markets Served
7.13.5 CSPC Pharmaceutical Recent Developments/Updates
7.14 Orchid Pharma
7.14.1 Orchid Pharma Antiinfective API Corporation Information
7.14.2 Orchid Pharma Antiinfective API Product Portfolio
7.14.3 Orchid Pharma Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Orchid Pharma Main Business and Markets Served
7.14.5 Orchid Pharma Recent Developments/Updates
7.15 Guangzhou Pi & Pi Biotech
7.15.1 Guangzhou Pi & Pi Biotech Antiinfective API Corporation Information
7.15.2 Guangzhou Pi & Pi Biotech Antiinfective API Product Portfolio
7.15.3 Guangzhou Pi & Pi Biotech Antiinfective API Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Guangzhou Pi & Pi Biotech Main Business and Markets Served
7.15.5 Guangzhou Pi & Pi Biotech Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Antiinfective API Industry Chain Analysis
8.2 Antiinfective API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Antiinfective API Production Mode & Process
8.4 Antiinfective API Sales and Marketing
8.4.1 Antiinfective API Sales Channels
8.4.2 Antiinfective API Distributors
8.5 Antiinfective API Customers
9 Antiinfective API Market Dynamics
9.1 Antiinfective API Industry Trends
9.2 Antiinfective API Market Drivers
9.3 Antiinfective API Market Challenges
9.4 Antiinfective API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
